Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 12, 1998, Pages 4435-4442

  Ringel, Matthew D ^a,b   Ladenson, Paul W ^a   Levine, Michael A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; RADIOACTIVE IODINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN;

ARTICLE; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE AMPLIFICATION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID CELL; THYROIDECTOMY; THYROTROPIN RELEASE;

EID: 0032461020     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.12.4435     Document Type: Article

References (52)

1. 1. American Cancer Society. 1995 Cancer facts and figures. Atlanta: American Cancer Society.
2. 2. National Cancer Institute. 1993 National Cancer Institute Fact Book. Washington DC: DHHS, USPHS, NIH.
3. 3. Dugelroff AJ, Hershman JM. 1994 Medical therapy for differentiated thyroid carcinoma. Endocr Rev. 15:500-515.
4. 4. Tangfui SCNG, Hoffenberg R, Maisey M, et al. 1979 Serum thyroglobulin concentrations and whole-body scan in follow-up of differentiated thyroid cancer after thyroid ablation. Br J Med. 2:298-300.
5. 131I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy). Clin Endocrinol (Oxf). 13:107-110.
6. 6. Van Herle AJ, Uller RP. 1973 Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas. J Clin Invest. 56:272-277.
7. 7. Ozata M, Suzuki S, Miyamoto Y, et al. 1994 Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab. 79:98-105.
8. 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer. J Clin Endocrinol Metab. 53:1199-1206.
9. 9. Girelli ME, Busanrdo B, Amerio R, et al. 1986 Critical evaluation of serum thyroglobulin (Tg) levels during thyroid hormone withdrawal and total body scan: results in 291 patients with thyroid cancer. Eur J Nucl Med. 11:333-335.
10. 10. Ladenson PW, Braverman LE, Mazaferri EL, et al. 1997 Comparison of recombinant human thyrotropin administration to thyroid hormone withdrawal for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med. 337:888-896.
11. 11. Robbins J, Merino MJ, Boice Jr JD, et al. 1991 Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med. 115:133-147.
12. 12. Sfakianakis GN, Skillman TG, George JM. 1975 Thyroxine withdrawal in thyroid cancer. Ohio State Med J. 71:78-82.
13. 13. Ligabue A, Poggioli MC, Zacchini A. 1993 Interference of specific autoantibodies in the assessment of serum thyroglobulin. J Nucl Biol Med. 37:273-279.
14. 14. Spencer CA, Wang CC. 1996 Thyroglobulin measurement: techniques, clinical benefits and pitfalls. Endocrinol Metab Clin North Am. 24:841-864.
15. 15. Olivieri A, Marzullo A, Salbe GB, et al. 1991 Isoelectric focusing and immunoblotting analysis of thyroglobulin from different thyroid diseases. Thyroidol. 3:13-16.
16. 16. Ditkoff BA, Marvin MR, Yemul S, Shi YJ, Chabot J, Feind C, Gerfo PL. 1996 Detection of circulating thyroid cells in peripheral blood. Surgery. 120:959-965.
17. 17. Tallini G, Ghossein R, Emanuel J, et al. 1998 Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol. 16:1158-1166.
18. 18. Katz AE, Olsson CA, Raffo AJ, et al. 1994 Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology. 43:765-775.
19. 19. Ghossein RA, Scher HI, Gerald WL, et al. 1995 Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol. 13:1195-1200.
20. 20. Jaakkola S, Vornanen T, Leinonen J, Rannikko S, Stenman UH. 1995 Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. Clin Chem. 41:182-186.
21. 21. Seiden MV, Kantoff PW, Krithivas K, et al. 1994 Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol. 12:2634-2639.
22. 22. Corey E, Arfman EW, Liu AY, Vessella RL. 1997 Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow. Clin Chem. 43:443-452.
23. 23. Moreno JG, Croce CM, Fischer R, et al. 1992 Detection of hematogenous micrometastases in patients with prostate cancer. Cancer Res. 52:6110-6112.
24. 24. Fadlon EJ, Rees RC, McIntyre C, Sharrard RM, Lawry J, Hamdy FC. 1996 Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction. Br J Cancer. 74:400-405.
25. 25. Smith B, Selby P, Southgate J, et al. 1991 Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet. 338:1227-1229.
26. 26. Proebstle TM, Huber R, Sterry W. 1996 Detection of early micrometastases in subcutaneous fat of primary malignant melanoma patients by identification of tyrosinase-mRNA. Eur J Cancer. 32A:1627-1629.
27. 27. Kruger W, Krzizanowski C, Holweg M, et al. 1996 Reverse transcriptase/ polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol. 122:679-686.
28. 28. Luppi M, Morselli M, Banderi E, et al. 1996 Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann Oncol. 7:619-624.
29. 29. Kruger WH, Stockschlader M, Hennings S, et al. 1996 Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture. Bone Marrow Transplant. 18(Suppl 1):S18-S20.
30. 30. Saiki RK, Gelfand DH, Stoffel SJ, et al. 1988 Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 239:487-491.
31. 31. Parma J, Christophe D, Pohl V, Vassart G. 1987 Structural organization of the 5′ region of the thyroglobulin gene. Evidence for intron loss and "exonization" during evolution. J Mol Biol. 196:769-779.
32. 32. Patten JL, Johns DR, Valle D, et al. 1990 Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med. 322:412-419.
33. 33. Miric A, Vechio J, Levine MA. 1993 Heterogeneous mutations in the gene encoding the α subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy. J Clin Endocrinol Metab. 76:1560-1568.
34. 34. Bertaux F, Noel M, Malthiery Y, et al. 1991 Demonstration of a heterogeneous transcription pattern of thyroglobulin mRNA in human thyroid tissue. Biochem Biophys Res Commun. 178:586-592.
35. 35. Wong LS, Bateman WJ, Morris AG, Fraser IA. 1995 Detection of circulating tumor cells with the magnetic activated cell sorter. Br J Surg. 82:1333-1337.
36. 36. Griwatz C, Brandt B, Assmann G, Zänker KS. 1995 An immunological enrichment method for epithelial cells from peripheral blood. J Immunol Methods. 183:251-165.
37. 37. Sarker G, Sommer SS. 1989 Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science. 244:331-334.
38. 38. Rosenzweig A, Watkins H, Hwang DS, et al. 1991 Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. N Engl J Med. 325:1753-1760.
39. 39. Charles MA, Dodson LE, Waldeck N, et al. 1980 Serum thyroglobulin levels predict total body iodine scan findings in patients with treated well-differentiated thyroid carcinoma. Am J Med. 69:401-407.
40. 40. Colacchio TA, LoGerfo P, Colacchio DA, et al. 1982 Radioiodine total body scan vs. serum thyroglobulin levels in follow-up of patients with thyroid cancer. Surgery. 91:42-45.
41. 41. Black EG, Sheppard MC. 1991 Serum thyroglobulin measurements in thyroid cancer: evaluation of "false positive" results. Clin Endocrinol (Oxf). 35:519-520.
42. 42. Pineda JD, Lee T, Ain K, Reynolds JC, Robbins J. 1995 Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab. 80:1488-1492.
43. 43. Dai G, Levy O, Carrasco N. 1996 Cloning and characterization of the thyroid iodide transporter. Nature. 379:458-460.
44. 44. Smanik P, Liu Q, Furminger TL, et al. 1996 Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun. 226:339-345.
45. 45. Arturi F, Russo D, Giuffrida D, Ippolito A, Perroti N, Vigneri R, Filetti S. 1997 Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab. 82:1638-1641.
46. 46. Garson JA, Tedder RS, Briggs M, et al. 1990 Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and predictions of infectivity. Lancet. 335:1419-1422.
47. 47. Ho DD, Mougdil T, Alam M. 1989 Quantitation of human immunodeficiency virus type I in the blood of infected persons. N Engl J Med. 321:1621-1625.
48. 48. Coombs RW, Collier AC, Allain J-P, et al. 1989 Plasma viremia in human immunodeficiency virus infection. N Engl J Med. 321:1626-1631.
49. 49. Pacini F, Mariotti S, Formica N, et al. 1988 Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome. Acta Endocrinol (Copenh). 119:373-380.
50. 50. Rubello D, Girelli ME, Casara D, Piccolo M, Perin A, Busnardo B. 1990 Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer. J Endocrinol Invest. 13:737-742.
51. 51 . Kumar A, Shah DH, Shrihari U, Dandekar SR, Vijayan U, Sharma SM. 1994 Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma. Thyroid. 4:199-202.
52. 52. Wang AM, Doyle MV, Mark DF. 1989 Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA. 86:9717-9721.